Viewing Study NCT02532192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2026-01-11 @ 11:18 PM
Study NCT ID: NCT02532192
Status: WITHDRAWN
Last Update Posted: 2016-01-06
First Post: 2015-08-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None Diffuse large B-cell lymphoma View
None DLBCL View
None Relapsed View
None Refractory View
None Belinostat View
None Rituximab View
None Rituxan View
None Cisplatin View
None Platinol-AQ View
None Platinol View
None CDDP View
None Cytarabine View
None Ara-C View
None Cytosar View
None DepoCyt View
None Cytosine arabinosine hydrochloride View
None Dexamethasone View
None Decadron View
None Ciprofloxacin View
None Ciprofloxacin hydrochloride View
None Cipro View
None Fluconazole View
None Diflucan View